Cargando…
Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
BACKGROUND: Paclitaxel (PTX) resistance is a major obstacle in the treatment of triple-negative breast cancer (TNBC). Previously, we have reported that interleukin-1 receptor-associated kinase 1 (IRAK1) and its downstream pathways are associated with PTX resistance in TNBC cells. In this study, we s...
Autores principales: | Wang, Panpan, Song, Dan, Wan, Danhong, Li, Lingyu, Mei, Wenhui, Li, Xiaoyun, Han, Li, Zhu, Xiaofeng, Yang, Li, Cai, Yu, Zhang, Ronghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275687/ https://www.ncbi.nlm.nih.gov/pubmed/32547883 http://dx.doi.org/10.7717/peerj.9281 |
Ejemplares similares
-
Anti-platelet activity of panaxatriol saponins is mediated by suppression of intracellular calcium mobilization and ERK2/p38 activation
por: Qi, Hongyi, et al.
Publicado: (2016) -
Panaxadiol and Panaxatriol Derivatives as Anti-Hepatitis B Virus Inhibitors
por: Chen, Hao, et al.
Publicado: (2014) -
Dimethyl Fumarate Induces Apoptosis via Inhibition of NF-κB and Enhances the Effect of Paclitaxel and Adriamycin in Human TNBC Cells
por: Tsurushima, Katsumasa, et al.
Publicado: (2022) -
miR-330–5p in Small Extracellular Vesicles Derived From Plastrum testudinis-Preconditioned Bone Mesenchymal Stem Cells Attenuates Osteogenesis by Modulating Wnt/β-Catenin Signaling
por: Li, Xiaoyun, et al.
Publicado: (2021) -
Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier
por: Yan, Bo, et al.
Publicado: (2022)